GSK PLC Sponsored ADR (GSK)
(Delayed Data from NYSE)
$40.01 USD
+0.15 (0.38%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $40.01 0.00 (0.00%) 5:30 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Brokerage Reports
GSK PLC Sponsored ADR [GSK]
Reports for Purchase
Showing records 241 - 252 ( 252 total )
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Medium-to-long term growth prospects depend on ability to record continued decent growth in emerging markets,vaccines & consumer healthcare businesses, improve late-stage pipeline productivity & maintain tight control on operating expenses...
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Medium-to-long term growth prospects depend on ability to record
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Biotech Balance Sheet
Provider: Merriman Curhan Ford & Co.